US Stock MarketDetailed Quotes

BRTH Breathe BioMedical

Watchlist
  • 0.000
  • 0.0000.00%
Close Mar 21 09:30 ET
0Market Cap0.00P/E (TTM)

Breathe BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
164.61%3.53M
75.40%8.9M
1.33M
11.41%5.07M
4.55M
Selling and administrative expenses
338.18%2.85M
101.89%6.7M
--650.6K
2.67%3.32M
--3.23M
-Selling and marketing expense
-99.27%89
-4.89%61.61K
--12.23K
-58.51%64.77K
--156.11K
-General and administrative expense
346.55%2.85M
104.02%6.64M
--638.37K
5.78%3.25M
--3.08M
Research and development costs
-9.34%571.35K
14.61%2.09M
--630.21K
13.91%1.82M
--1.6M
Depreciation amortization depletion
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
-Depreciation and amortization
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
Other operating expenses
35.41%-25.76K
17.18%-271.5K
---39.87K
34.29%-327.83K
---498.91K
Operating profit
-164.61%-3.53M
-75.40%-8.9M
-1.33M
-11.41%-5.07M
-4.55M
Net non-operating interest income expense
-323.87%-10.6K
-211.55%-16.15K
4.73K
19.46%14.48K
12.12K
Total other finance cost
323.87%10.6K
211.55%16.15K
---4.73K
-19.46%-14.48K
---12.12K
Other net income (expense)
18.76%203.85K
-7.82%555K
171.65K
5.27%602.07K
571.95K
Gain on sale of security
16.92%5.6K
-166.07%-4.27K
--4.79K
-53.24%6.46K
--13.82K
Other non- operating income (expenses)
18.81%198.25K
-6.10%559.27K
--166.86K
6.71%595.6K
--558.13K
Income before tax
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Income tax
0
0
0
0
0
Net income
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Net income continuous Operations
-188.25%-3.34M
-87.57%-8.36M
---1.16M
-12.28%-4.46M
---3.97M
Minority interest income
Net income attributable to the parent company
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Basic earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Diluted earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 164.61%3.53M75.40%8.9M1.33M11.41%5.07M4.55M
Selling and administrative expenses 338.18%2.85M101.89%6.7M--650.6K2.67%3.32M--3.23M
-Selling and marketing expense -99.27%89-4.89%61.61K--12.23K-58.51%64.77K--156.11K
-General and administrative expense 346.55%2.85M104.02%6.64M--638.37K5.78%3.25M--3.08M
Research and development costs -9.34%571.35K14.61%2.09M--630.21K13.91%1.82M--1.6M
Depreciation amortization depletion 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
-Depreciation and amortization 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
Other operating expenses 35.41%-25.76K17.18%-271.5K---39.87K34.29%-327.83K---498.91K
Operating profit -164.61%-3.53M-75.40%-8.9M-1.33M-11.41%-5.07M-4.55M
Net non-operating interest income expense -323.87%-10.6K-211.55%-16.15K4.73K19.46%14.48K12.12K
Total other finance cost 323.87%10.6K211.55%16.15K---4.73K-19.46%-14.48K---12.12K
Other net income (expense) 18.76%203.85K-7.82%555K171.65K5.27%602.07K571.95K
Gain on sale of security 16.92%5.6K-166.07%-4.27K--4.79K-53.24%6.46K--13.82K
Other non- operating income (expenses) 18.81%198.25K-6.10%559.27K--166.86K6.71%595.6K--558.13K
Income before tax -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Income tax 00000
Net income -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Net income continuous Operations -188.25%-3.34M-87.57%-8.36M---1.16M-12.28%-4.46M---3.97M
Minority interest income
Net income attributable to the parent company -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Basic earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Diluted earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Dividend per share
Currency Unit CADCADCADCADCAD

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
248.710
Apple
AAPL
218.270
Meta Platforms
META
596.250
4
Intel
INTC
24.260
5
Microsoft
MSFT
391.260
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025